Jon Hopper, MBChB Recruited to Osiris Therapeutics
Former Vice President, Global Medical Director, Stryker
Life Science Partner recruited Jon Hopper, MBChB, an accomplished physician executive to become Chief Medical Officer for Osiris Therapeutics. Osiris is the leading stem cell company focused on developing products to treat conditions in wound care, orthopedic and sports medicine markets.
Hopper joins Osiris after serving as the Vice President, Global Medical Director at Stryker. In his new role, Hopper will report directly to CEO Lode Debrabandere and oversee medical affairs, clinical development and regulatory affairs globally. He will be responsible for providing high-level market strategy for Osiris’ leadership within regenerative medicine.
“Hopper has a worldview of developing and marketing both orthopedic and wound healing products in the US, Asia and Europe,” notes Tom Callaway, MD, President of Life Science Partner. “He has helped developing clinical and post-marketing plans for complex biologic products including living cells.”
Hopper earned both his Bachelor of Science Degree in Anatomical Studies and his MB ChB from the University of Birmingham, UK.
Leave a ReplyWant to join the discussion?
Feel free to contribute!